Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hyperfine, Inc. - Class A Common Stock (NQ:HYPR)

1.005 +0.085 (+9.26%)
Streaming Delayed Price Updated: 11:50 AM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hyperfine, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
From Hyperfine, Inc.
Via Business Wire
Recap: Hyperfine Q3 Earnings
Via Benzinga
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Recap: Hyperfine Q1 Earnings
Via Benzinga
Hyperfine's Earnings: A Preview
Via Benzinga
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives
From Hyperfine, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase
From Hyperfine, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer
From Hyperfine, Inc.
Via Business Wire
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Reports First Quarter 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of... 
Via Benzinga
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
From Hyperfine, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.